Stephanie Lee
Investor Relations
Replay available
Roivant Sciences Ltd. (NASDAQ: ROIV) Q4 2025 earnings conference call, held 2026-05-20. Replay captured from the company's public earnings webcast.

Investor Relations
Analyst, TD Cowen
Analyst, Piper Sandler
Analyst, Jefferies
Analyst, Cantor Fitzgerald
Analyst, DHC Wainwright
Chief Executive Officer
Chief Executive Officer
Analyst, Wells Fargo
Analyst, Laring Partners
Analyst, Stifel
Analyst, Wolfe Research
Analyst, Lyric Partners
Analyst, J.P. Morgan
Analyst, Bernstein
Analyst, Bank of America Securities
Analyst, Goldman Sachs
Analyst, Guggenheim
Analyst, LifeSci Capital
Ladies and gentlemen, thank you for standing by. Welcome to the Roy Van Forth Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. And to ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. We ask that you please limit to one question. And to withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would like now to turn the conference over to Stephanie Lee. Please go ahead. Good morning, and thanks for joining today's call to review business updates from Roy Vint's fourth quarter and fiscal year ended March 31, 2026. I'm Stephanie Lee with Roy Vint. Presenting today, we have Matt Glein, CEO of Oregon, and Drew Brumkin, CEO of Palmogans. For those dialing in via conference call, you can find the slides being presented today, as well as the press release announcing these updates on our IR website at www.investor.rogan.com. We'll also be providing the current slide numbers as we present to help you follow along. I'd like to remind you that we'll be making certain forward-looking statements during today's presentation. We strongly encourage you to review the information that we have filed with the SEC for more information regarding these forward-looking statements and related risks and uncertainties. And with that, I'll turn it over to Matt. Thanks, Stephanie. Thank you, everyone, for dialing in this morning. I'm glad to be talking. We have an unexpectedly busy agenda with a bunch of topics. I'm looking forward to going through all of it, including, obviously, what we announced this morning, which is ...